Leukemia Clinical Trials

Showing 2741-2760 of 10,987 trials

Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan

NCT06358222

This is a single center, prospective and observational study conducted in three stages to predict the NSCLC lymph node metastasis based on ctDNA/specific methylation molecular features combined with PET-CT imaging features and intervention study.

CarcinomaNon-small Cell Lung Cancer

Shanghai Chest Hospital200 participantsStarted Dec 2023

Shanghai, China

Active Not RecruitingPhase 1/2

A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML

NCT04730258

The purpose of this study is to test the safety of an investigational drug called CFI-400945 alone and in combination with azacitidine.

Acute Myeloid LeukemiaMyelodysplastic SyndromesChronic Myelomonocytic Leukemia+3 more

Treadwell Therapeutics, Inc72 participantsStarted Apr 2021

Duarte, California, United States • Sacramento, California, United States • Louisville, Kentucky, United States +6 more locations

Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan

A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML

Related Searches

Non-Guided vs. Guided Surgery to Immediately Loaded PrimeTaper Implants in Partially Edentulous Patients

TGRX-326 Chinese Phase I for Advanced Non-small Cell Lung Cancer (NSCLC)

Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease

Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid Leukemia

Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer

TGRX-326 Pharmacokinetic Food Effect Bioavailability Study

BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS

Phase II Study of Anti-CD19 CAR-T Cells Treating Leukemia Children

A Study of Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant

Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)

VAY736 in Combination With Ibrutinib in Patients With CLL on Ibrutinib

Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia

Trial of Trametinib and Ponatinib in Patients With KRAS Mutant Advanced Non-Small Cell Lung Cancer

A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC

TGRX-678 Phase I Oral Pharmacokinetic Study

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer

Explore the Therapeutic Effect of Theta Burst Stimulation on Emotion Regulation in Autism With Minimally Verbal Ability or Intellectual Disability